tella, Inc. (JASDAQ:2191) agreed to acquire 51% stake in Prometheus Biotech Corporation from Cenegenics Japan Co., Ltd. for approximately ¥150 million on August 25, 2020. tella, Inc. signed share transfer agreement to acquire 51% stake in Prometheus Biotech Corporation from Cenegenics Japan Co., Ltd. on August 26, 2020. Under the transaction, tella, Inc. will acquire 1,530 shares of Prometheus Biotech Corporation. Post completion, Prometheus Biotech Corporation will operate as a subsidiary of tella, Inc. The transaction was resolved by the Board of tella, Inc. on August 25, 2020. The transaction is expected to close on August 26, 2020. tella, Inc. (JASDAQ:2191) completed the acquisition of 51% stake in Prometheus Biotech Corporation from Cenegenics Japan Co., Ltd. on August 26, 2020.